The effect of enteral administration of glutamine supplement for the prevention of ventilator associated pneumonia

Evaluation of the effect of enteral administration of glutamine supplement for the prevention of ventilator associated pneumonia in critically ill patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150221021159N5

Enrollment

Registered

2020-06-30

Start date

2019-10-23

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator associated pneumonia. Ventilator associated pneumonia

Interventions

Intervention 1: Intervention group: Forty milligram of glutamin powder was administered via enteral rout, for 7 days. Intervention 2: Control group: No intervention was conducted.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients undergoing mechanical ventilation for 48 hours

Exclusion criteria

Exclusion criteria: Diagnosis of acute respiratory distress syndrome or Pneumonia at intensive care unit (ICU) admission

Design outcomes

Primary

Measure	Time frame
Prevention of ventilator associated pneumonia. Timepoint: Evaluation of the occurrence of ventilator associated pneumonia daily, during 14 days after study recruitment. Method of measurement: Calculate the clinical pulmonary infection score (CPIS) table.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShadi Farsaei

Esfahan University of Medical Sciences

Farsaei@pharm.mui.ac.ir+98 31 3792 7071

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026